FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.2  |  FHIR Version n/a  User: [n/a]

409405006: Product containing bevacizumab (medicinal product)

Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2018. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3522874013 Product containing bevacizumab (medicinal product) en Fully specified name Active Entire term case insensitive SNOMED CT core module
3713532017 Bevacizumab-containing product en Synonym Active Entire term case insensitive SNOMED CT core module

27 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Product containing bevacizumab Is a Product containing angiogenesis inhibitor true Inferred relationship Existential restriction modifier
Product containing bevacizumab Is a Product containing monoclonal antibody false Inferred relationship Existential restriction modifier
Product containing bevacizumab Has active ingredient Monoclonal antibody false Inferred relationship Existential restriction modifier
Product containing bevacizumab Has active ingredient Bevacizumab true Inferred relationship Existential restriction modifier 1
Product containing bevacizumab Has active ingredient Immunosuppressant false Inferred relationship Existential restriction modifier
Product containing bevacizumab Is a Medicinal product acting as antineoplastic agent (product) false Inferred relationship Existential restriction modifier
Product containing bevacizumab Plays role Antineoplastic therapeutic role true Inferred relationship Existential restriction modifier
Product containing bevacizumab Is a Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product) true Inferred relationship Existential restriction modifier
Product containing bevacizumab Is a Virtual therapeutic moiety false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Bevacizumab 25mg/mL injection solution 4mL vial Is a False Product containing bevacizumab Inferred relationship Existential restriction modifier
Bevacizumab 25mg/mL injection solution 16mL vial Is a False Product containing bevacizumab Inferred relationship Existential restriction modifier
Product containing bevacizumab in parenteral dose form (medicinal product form) Is a True Product containing bevacizumab Inferred relationship Existential restriction modifier
Bevacizumab Is a True Product containing bevacizumab Inferred relationship Existential restriction modifier
Bevacizumab 5mg/0.2ml solution for injection pre-filled syringes Is a False Product containing bevacizumab Inferred relationship Existential restriction modifier
Bevacizumab 1.25mg/0.05ml solution for injection vials Is a False Product containing bevacizumab Inferred relationship Existential restriction modifier
Bevacizumab 1.25mg/0.05ml solution for injection pre-filled syringes Is a False Product containing bevacizumab Inferred relationship Existential restriction modifier
Bevacizumab 1% eye drops Is a False Product containing bevacizumab Inferred relationship Existential restriction modifier
Bevacizumab 100mg/4ml solution for infusion vials Is a False Product containing bevacizumab Inferred relationship Existential restriction modifier
Bevacizumab 400mg/16ml solution for infusion vials Is a False Product containing bevacizumab Inferred relationship Existential restriction modifier
Bevacizumab 100mg/4ml solution for infusion vials Is a False Product containing bevacizumab Inferred relationship Existential restriction modifier
Bevacizumab 400mg/16ml solution for infusion vials Is a False Product containing bevacizumab Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start